A randomised, double-blind, placebo-controlled study to assess the efficacy and safety of soluble beta-1,3/1,6-glucan (SBG) in chronic foot ulcers in patients with diabetes

To compare the proportion of patients who have healing of their target ulcer within 8 weeks after starting topical treatment with SBG or placebo.